Loading clinical trials...

Synergistic Impact of Postural Correction Interventions and Sustained Natural Apophyseal Glides in Migraine | Clinical Trials | Clareo Health

COMPLETEDNA

Synergistic Impact of Postural Correction Interventions and Sustained Natural Apophyseal Glides in Migraine

Synergistic Impact of Postural Correction Interventions and Sustained Natural Apophyseal Glides on Severity, Disability and Quality of Life in Patients With Migraine

NCT07403175•Riphah International University

View on ClinicalTrials.gov

Summary

This study was conducted to evaluate the synergistic impact of postural correction interventions and sustained natural apophyseal glides on severity, quality of life and disability in patients with migraine.

Eligibility

Age

22 - 45 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•A diagnosis of episodic migraine made by the primary investigator according to ICHD-2.
•Symptoms must include at least two of the following: Unilateral pain, Pulsating/throbbing pain, Nausea, Vomiting, Photophobia/phonophobia.
•Participants should be full time employees or Desktop users.
•Participants have a history of at least migraine \>4 days per month.
•Participants having history of migraine lasting from 4-72 hours
•Age group between 22 and 45 years.
•Both gender male and female.
•Participants who agree to cut-off any pharmacological treatment during study.
•Participants should have an average score between 3-6 on pain intensity scale.

Exclusion Criteria

•Participants having active migraine and other headache types e.g. Cluster headache.
•Previous neck/head trauma from \>2 years.
•Any neck/head surgery \>2 years
•Spinal infections/diseases e.g. Tumor, TB spine
•Any history of neurological disorders e.g. stroke, abcess, haemorrhage, haematoma
•Severe Osteoporosis
•Pregnancy
•Upper motor neuron disease, cervical stenosis, and metabolic diseases in bone and joint.
•Ongoing radiotherapy, chemotherapy, steroid therapy, or anticoagulants.
•Psychiatric diseases such as phobia/obsession and depression.

Locations (1)

Abdul Ahaad Hospital, Sialkot

Sialkot, Punjab Province, Pakistan

Key Dates

Start Date

January 10, 2025

Primary Completion Date

October 31, 2025

Completion Date

October 31, 2025

Last Updated

February 11, 2026

Enrollment

ACTUAL participants

Conditions

Migraine

Interventions

Sustained Natural Apophyseal Glides

OTHER

Postural Correction Exercises

OTHER

Conventional Physical Therapy

OTHER

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

NCT07018713

Chronic Migraine

View study

RECRUITINGPHASE3

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

NCT06641466

Menstrual Migraine

View study

RECRUITINGNA

Mind Body Balance for Pediatric Migraine

NCT04715685

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 11, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Synergistic Impact of Postural Correction Interventions and Sustained Natural Apophyseal Glides in Migraine

Inclusion Criteria

Exclusion Criteria

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Mind Body Balance for Pediatric Migraine

Light Exposure, Migraine Outcomes, and Sleep Quality

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

Prophylactic Treatment With Atorvastatin for Episodic Migraine.